News

Tag: COVID -19

JPEO-CBRND Embraces the Need for Speed in Biodefense: How JPEO is Shaping its Biological Defense and Medical Strategies
August 11, 2023 — Biological incidents possess an alarming ability to wreak havoc on a massive scale, capable of rapidly escalating beyond the scale seen during COVID-19. The need lies in developing solutions that surpass the speed of these threats. Our warfighters need to swiftly defend themselves against a biological threat, or better yet, prevent it entirely, to... MORE

Army Medic in a medical gown administers a COVID test to a service member sitting in a chair in Italy.

Capacity Expansion Team Bolsters Nation’s Vaccine Industrial Base in Response to COVID-19
April 27, 2023 — At the height of the COVID-19 pandemic, supply chain shortfalls prevented Americans from finding basic items like toilet paper and cleaning supplies. Factory shutdowns emphasized the fact that most American manufacturing took place overseas. The domino effect was felt far and wide and was further illuminated once COVID-19 vaccines were available to... MORE

Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center, Fort Sam Houston, Texas, November 16, 2020. BAMC and Wilford Hall Ambulatory Surgical Center are participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

Lawyers and Pandemic Response: How the Joint Assisted Acquisition (JA2) Legal Cell Joined the Fight Against COVID-19
April 18, 2023 — President Biden announced that in May 2023, the U.S. will officially end its emergency response posture to the COVID-19 pandemic. This announcement marks a significant milestone in a long and difficult journey. From masks, to at-home test kits, to vaccines, countless experts worked tirelessly behind the scenes to develop the products and solutions... MORE

Ten people in business attire stand in front of flags and hold certificates of appreciation and award for service.

NSWC Crane employee serves public health overseeing $900M portfolio as U.S. expands vaccine and therapeutic manufacturing supply chain
December 14, 2022 — A Naval Surface Warfare Center, Crane Division (NSWC Crane) employee is serving on a detail overseeing a $900 million portfolio to expand the U.S. vaccine and therapeutic manufacturing supply chain. Over the past two years, these investments and partnerships with industry have developed into the construction of new manufacturing facilities across the country to develop future vaccine and therapeutic capabilities. The JPEO-CBRND and the Army Contracting Command were leveraged to assist the Biomedical Advanced Research and Development Authority, which is an office in the U.S. Department of Health and Human Services, who were tasked in 2020 to ensure that every COVID-19 vaccine, therapeutic, and test kit were bought, packaged, and delivered to the Nation. The JPEO-CBRND has a special Joint Assisted Acquisition (JA2) team, established by the May 2021 memorandum of understanding between DoD and HHS, which supports the continued contracting and acquisition expertise needed for the Nation’s ongoing mission to fight the coronavirus, including partnerships with the Federal COVID-19 Response interagency team, academia and the American industrial base... MORE

Naval Surface Warfare Center, Crane Division - Heather Baladi, NSWC Crane

DoD Awards $1.74 Billion Agreement to Moderna, Inc. to Secure Over 65 Million Doses of COVID-19 Vaccine for Fall Vaccinations
July 29, 2022 — On July 28, 2022, the Department of Defense (DoD), on behalf of and in coordination with the U.S. Department of Health and Human Services (HHS), awarded a $1.74 billion agreement to purchase over 65 million doses of Moderna’s COVID-19 vaccine for a fall vaccination campaign. The vaccine will target the SARS-CoV-2 Omicron subvariant viruses, as... MORE

Biden-Harris Administration secures 3.2 million doses of Novavax COVID-19 Vaccine
July 11, 2022 — Latest vaccine will provide an additional option for the American public, pending FDA Emergency Use Authorization and CDC recommendation... MORE

A servicemember sits in a yellow shirt in front of a table of red and blue testing vials. Covi

Biden-Harris Administration Secures More Than 100 Million Doses of Pfizer's Latest COVID-19 Vaccine for Fall Vaccine Campaign
June 29, 2022 — The U.S. Department of Health and Human Services (HHS), in collaboration with the Department of Defense (DOD), announced an agreement to purchase more than 100 million doses of Pfizer’s COVID-19 vaccine for a fall vaccine campaign. The contract announcement follows a June 28, 2022 meeting of the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee, which recommended the inclusion of an Omicron component for COVID-19 booster vaccines in the U.S. To award the contract, the Biomedical Advanced Research and Development Authority (BARDA), part of ASPR, collaborated with the DOD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) who led this effort in partnership with the Defense Assisted Acquisition Cell (DA2) and U.S. Army Contracting Command... MORE

In the foreground a hand holding an orange sticker that says "I got my vaccine". In the background there are three medical personnel wearing personal protective equipment.

DOD Awards $79.9 Million Contract to Premix, Inc. to Onshore Production Capacity of Resin for Pipette Tips Required for COVID-19 Diagnostic Testing
May 11, 2022 — On May 5, 2022, the Department of Defense (DOD), on behalf of and in coordination with the U.S. Department of Health and Human Services (HHS), awarded a $79.9 million contract to Premix, Inc. to establish production of a plastic compound primarily used for pipette tips, which are essential to COVID-19 and other diagnostic testing efforts. Premix,... MORE

Two uniformed service members are in a tent. One wears PPE and a faceshield, while they use a nasal swab to collect a COVID-19 sample from the other Service member in uniform.

DoD Awards Contract Modifications to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS’ One Billion Free At-Home COVID-19 Tests
March 28, 2022 — In the month of March, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded contract modifications to Abbott Rapid Dx North America, LLC (Orlando, Florida) and iHealth Labs Inc. (Sunnyvale, California), purchasing an additional 176.8 million over-the-counter COVID-19 test kits. The DoD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) led this effort in partnership with DoD’s Defense Assisted Acquisition Cell (DA2), Army Contracting Command, and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR). The procurement was funded through the American Rescue Plan Act to supply critical medical resources to the nation... MORE

DOD Awards Contracts to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS’ One Billion Free At-Home COVID-19 Tests
February 18, 2022 — This week, the DoD, in coordination with HHS, awarded contract modifications to Roche Diagnostics Corporation and Siemens Healthineers purchasing a combined total of 138 million over-the-counter COVID-19 test kits. The JPEO-CBRND led this effort in partnership with DoD’s Defense Assisted Acquisition Cell (DA2), Army Contracting Command, and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR). The procurement was funded through the American Rescue Plan Act to supply critical medical resources to the nation... MORE

American flags against a blue sky background

News Search

News Archive - Search by Year and Month

2024 (33)
2023 (36)
2022 (31)
2021 (37)
2020 (15)
2019 (11)
2018 (5)
2017 (9)
2016 (1)

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.